Page Banner

United States Department of Agriculture

Agricultural Research Service

Juli A Foster Frey
Animal Biosciences and Biotechnology Laboratory
Molecular Biologist

Phone: (301) 504-8119
Fax: (301) 504-8571
10300 BALTIMORE AVENUE
BLDG 230 BARC-EAST
BELTSVILLE, MD, 20705-2350


Publications (Clicking on the reprint icon Reprint Icon will take you to the publication reprint.)
Triple-acting antimicrobial treatment for drug-resistant and intracellular Staphylococcus aureus. - (Abstract Only) - (21-May-14)
Triple-acting antimicrobial treatment for drug-resistant and intracellular Staphylococcus aureus - (Abstract Only) - (28-Apr-14)
Sperm-mediated transgenesis in chicken using a PiggyBac transposon system - (Abstract Only) - (11-Apr-14)
Triple-acting antimicrobial treatment for drug-resistant and intracellular Staphylococcus aureus - (Abstract Only) - (01-Apr-14)
Sperm-mediated transgenesis in chicken using a PiggyBac transposon system - (Abstract Only) - (20-Mar-14)
Triple-acting Peptidoglycan hydrolase treatment for drug-resistant and intracellular Staphylococcus aureus - (Abstract Only) - (18-Mar-14)
Bacteriophage endolysin production in Nicotiana benthamiana plants - (Abstract Only) - (24-Jun-13)
Staphylococcal phage 2638a endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain cryptic translational start site. - (Peer Reviewed Journal)
Abaev, I., Foster Frey, J.A., Korobova, O., Shishkova, N., Kopylov, P., Pyramchuk, S., Schmelcher, M., Becker, S.C., Donovan, D.M. 2013. Staphylococcal phage 2638a endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain cryptic translational start site. Applied and Environmental Microbiology. 97(8):3449-3456.
Lysostaphin: molecular changes that preserve staphylolytic activity. - (Proceedings) - (20-Feb-11)
Peptidoglycan hydrolase fusion to protein transduction domains kill intracellular staphylococci. - (Abstract Only)
Becker, S.C., Foster Frey, J.A., Willard, R.R., Lease, R.A., Almeida, R., Marriott, I., Dong, S., Baker, J.R., Pritchard, D.G., Donovan, D.M. 2009. Peptidoglycan hydrolase fusion to protein transduction domains kill intracellular staphylococci. Evergreen International Phage Meeting.
Peptidoglycan Hydrolases for Control of Mastitis Pathogens - (Abstract Only)
Schmelcher, M., Becker, S.C., Foster Frey, J.A., Donovan, D.M. 2009. Peptidoglycan Hydrolases for Control of Mastitis Pathogens. Evergreen International Phage Meeting.
Engineering Antimicrobials Refractory to Resistance - (Abstract Only)
Becker, S.C., Pohl, C.S., Mohammadi, H., Schmelcher, M., Foster Frey, J.A., Lease, R.A., Don, S., Baker, J.R., Pritchard, D.G., Donovan, D.M. 2009. Engineering Antimicrobials Refractory to Resistance. Evergreen International Phage Meeting.
Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain. - (Peer Reviewed Journal)
Becker, S.C., Foster-Frey, J., Stodola, A.J., Anacker, D., Donovan, D.M., 2009. Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer identical staphylolytic activity to a streptococcal prophage endolysin lytic domain. FEMS Immunology and Medical Microbiology. 443(1-2):32-41.
Antimicrobials for staphylococcal pathogens that are refractory to resistance development - (Abstract Only)
Becker, S.C., Foster Frey, J.A., Willard, R.R., Lease, R.A., Almeida, R., Marriott, I., Dong, S., Pritchard, D.G., Donovan, D.M. 2009. Antimicrobials for staphylococcal pathogens that are refractory to resistance development. International Symposium on Antimicrobial Peptides.
Antimicrobials for mastitis causing pathogens that are refractory to resistance development - (Abstract Only)
Becker, S.C., Don, S., Baker, J.R., Foster Frey, J.A., Pritchard, D.G., Donovan, D.M. 2009. Antimicrobials for mastitis causing pathogens that are refractory to resistance development. BARC Poster Day.
Peptidoglycan hydrolase enzyme fusions are uniquely suited for treating multi-drug resistant pathogens - (Review Article)
Donovan, D.M., Becker, S.C., Dong, S., Baker, J.R., Foster Frey, J.A., Pritchard, D.G. 2009. Peptidoglycan hydrolase enzyme fusions are uniquely suited for treating multi-drug resistant pathogens. Biotech International 21(2):6-10.
LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. - (Peer Reviewed Journal)
Becker, S.C., Don, S., Baker, J.R., Foster Frey, J.A., Pritchard, D.G., Donovan, D.M. 2009. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiology Letter. 294(1):52-60.
Engineering MRSA antimicrobials that are refractory to resistance development - (Abstract Only)
Becker, S.C., Donovan, D.M., Foster Frey, J.A. 2008. Engineering MRSA antimicrobials that are refractory to resistance development. BARC Poster Day.
Resolving the database sequence discrepancies for the Staphylococcus aureus bacteriophage phi 11 amidase. Reprint Icon - (Peer Reviewed Journal)
Donovan D.M., Foster-Frey J., Garrett W.M., Blomberg, L. 2008. Resolving the database sequence discrepancies for the Staphylococcus aureus bacteriophage phi11 amidase. Journal of Basic Microbiology. 48(1):48-52.
Designer Antimicrobials: Peptidoglycan Hydrolase Module Shuffling - (Abstract Only) - (30-Oct-06)
Bacteriophage Phi11 Endolysin Has Antimicrobial Activity Against the Mastitis Pathogens Staphylococcus Aureus and Coagulase Negative Staphylococcus - (Peer Reviewed Journal)
Donovan, D.M., Foster Frey, J.A. 2006. Bacteriophage phi11 endolysin has antimicrobial activity against the mastitis pathogens staphylococcus aureus and coagulase negative staphylococcus. Applied and Environmental Microbiology. 265(1):133-139.
The Cell Lysis Activity of the Streptococcus Agalactiae Bacteriophage B30 Endolysin Relies on the Chap Endopeptidase Domain. - (Peer Reviewed Journal)
Donovan, D.M., Foster Frey, J.A., Dong, S., Rousseau, G., Moineau, S., Pritchard, D.G. 2006. The cell lysis activity of the streptococcus agalactiae bacteriophage b30 endolysin relies on the chap endopeptidase domain. Applied Environmental Microbiology. 72:5108-5112.
Designer Antimicrobials: Peptidoglycan Hydrolase Module Shuffling - (Abstract Only)
Donovan, D.M., Dong, S., Garrett, W.M., Foster Frey, J.A., Rousseau, G.M., Moineau, S., Pritchard, D.G. 2006. Designer Antimicrobials: Peptidoglycan Hydrolase Module Shuffling. American Society for Microbiology.
Follicular Expression of a Human Beta-Cell Leukemia/lymphoma-2 (Bcl-2)transgene Does Not Decrease Atresia Or Increase Ovulation Rate in Swine - (Peer Reviewed Journal)
Guthrie, H.D., Wall, R.J., Pursel, V.G., Foster Frey, J.A., Donovan, D.M., Dawson, H.D., Welch, G.R., Garrett, W.M. 2005. Follicular expression of a human B-cell leukemia/lymphoma-2 (Bcl-2)transgene does not decrease atresia or increase ovulation rate in swine. Journal Of Reproduction, Fertility And Development. 17(4):457-468.
Follicular Expression of a Human Beta-Cell Leukemia/lymphoma-2 (Bcl-2)transgene Does Not Decrease Atresia Or Increase Ovulation Rate in Swine. - (Abstract Only)
Guthrie, H.D., Wall, R.J., Pursel, V.G., Foster Frey, J.A., Donovan, D.M., Welch, G.R., Garrett, W.M. 2004. Follicular expression of a human beta-cell leukemia/lymphoma-2 (bcl-2)transgene does not decrease atresia or increase ovulation rate in swine. Society for the Study of Reproduction Annual Meeting. Abstract. p275.
Molecular Characterization of Lysozyme Type II Gene in Rainbow Trout. - (Peer Reviewed Journal)
Mitra, A., Foster-Frey, J. A., Wells,K. D., Rexroad,C. E. III, Wells,K. D. and Wall,R. J. (2003) Molecular Characterization lysozyme type II gene in rainbow trout (Oncorhynchus mykiss): Evidence of Gene Duplication. Animal Biotechnology 14:7-12.
DNA Preparation Method Can Influence Outcome of Transgenic Animal Experiments. - (Peer Reviewed Journal)
Wall, R.J., Paleyanda, R., Foster Frey, J.A., Powell, A.M., Rexroad, Jr., C.E., Lubon, H. 2000. DNA preparation method can influence outcome of animal experiments. Animal Biotechnology Journal. 11:19-32.
Codon Optimization, Genetic Insulation, and An Rtta Reporter Improve Performance of the Tetracycline Switch. - (Peer Reviewed Journal) - (14-Jul-99)
Last Modified: 9/10/2014
Footer Content Back to Top of Page